← Back to Search

Non-invasive Brain Stimulation

High-dose accelerated rTMS for Mild Cognitive Impairment (PUSH-Pilot Trial)

N/A
Waitlist Available
Led By Andreana Benitez, PhD
Research Sponsored by Medical University of South Carolina
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline prior to treatment and at follow-up within 1 week post-treatment
Awards & highlights

PUSH-Pilot Trial Summary

This trial is testing whether high-dose transcranial magnetic stimulation is a safe and effective treatment for mild cognitive impairment.

Eligible Conditions
  • Mild Cognitive Impairment

PUSH-Pilot Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline prior to treatment and at follow-up within 1 week post-treatment
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline prior to treatment and at follow-up within 1 week post-treatment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change From Baseline Global Cognition, as Measured by the Montreal Cognitive Assessment (MoCA)
Change in the Review of Systems Criteria Compared to Baseline
Number of Participants With Clinically Significant Structural Brain Change on T1- and T2-weighted Magnetic Resonance Imaging (MRI)
+2 more
Secondary outcome measures
Change From Baseline Cognition, as Measured by the Fluid Cognition Composite Score From the NIH Toolbox Cognition Battery
Change From Baseline Depression, as Measured by the Geriatric Depression Scale (GDS)
Change From Baseline Depression, as Measured by the Hamilton Depression Rating Scale (HAM-D)

PUSH-Pilot Trial Design

1Treatment groups
Experimental Treatment
Group I: High-dose accelerated rTMSExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
High-dose accelerated rTMS
2021
N/A
~30

Find a Location

Who is running the clinical trial?

National Center of Neuromodulation for RehabilitationUNKNOWN
10 Previous Clinical Trials
207 Total Patients Enrolled
Medical University of South CarolinaLead Sponsor
933 Previous Clinical Trials
7,394,611 Total Patients Enrolled
Andreana Benitez, PhDPrincipal Investigator - Medical University of South Carolina
Medical University of South Carolina
2 Previous Clinical Trials
109 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~6 spots leftby Apr 2025